Evidence map›Paper›PMID 42566118›Full record

ReviewTranslational stroke research2026

From Recanalization to Failed Recovery: No Reflow, No Rescue, and No Regrow After Thrombectomy.

Ariana Chacon, Dareen Hijazi, Ali Tfaily, Brian M Howard, Stephen Tomlinson, Jonathan A Grossberg, Ali M Alawieh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ariana ChaconDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Dareen HijaziDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Ali TfailyDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Brian M HowardDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Stephen TomlinsonDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleson, SC, USA.
Jonathan A GrossbergDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA.
Ali M AlawiehDepartment of Neurosurgery, Emory University School of Medicine, 1365 Clifton Rd, Suite B6200, Atlanta, GA, 30322, USA. ali.mostafa.alawieh@emory.edu.ORCID http://orcid.org/0000-0003-2601-8850

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the remarkable technical success of endovascular thrombectomy (EVT) in achieving high recanalization rates for acute ischemic stroke due to large vessel occlusion (LVO), angiographic success does not consistently translate into functional recovery. Approximately 50% of successfully recanalized patients failed to achieve functional independence at 90 days, a phenomenon termed futile recanalization (FR). Futile recanalization highlights the biological limitations of macrovascular reperfusion alone. We propose a mechanistic framework for FR centered on the "3 R's" of stroke recovery: No-Reflow, No-Rescue, and No-Regrow. No-Reflow refers to microvascular failure despite proximal recanalization, driven by capillary obstruction, endothelial injury, pericyte constriction, and thromboinflammatory processes. No-Rescue describes secondary loss of initially salvageable neurons due to complement activation, neuroinflammation, oxidative stress, and blood-brain barrier dysfunction. No-Regrow reflects impaired neuroplasticity in the subacute and chronic phases, including failed neurogenesis, axonal degeneration, white matter injury, and disrupted network reorganization. This review examines the clinical, imaging, procedural, and molecular determinants of FR to better understand why successful reperfusion does not always result in neurological recovery. Understanding the multifactorial nature of FR is essential to improving EVT outcomes. Future strategies should target microvascular injury and inflammation, refine patient selection criteria, and explore adjunctive therapies aimed at restoring downstream perfusion and mitigating neuroinflammation. By addressing both macrovascular and microvascular factors, it may be possible to translate angiographic success into meaningful functional recovery.

Indexed as

Ischemic StrokeNo-Reflow PhenomenonRecovery of FunctionThrombectomyAnimalsHumansFutile recanalizationMicrocirculatory dysfunctionNeuroinflammationNo-reflow phenomenonStrokeTICI–Rankin mismatch

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.